News Category
Quantum BioPharma received FDA clearance to begin Phase 2 trials for its novel MS candidate Lucid-MS, which targets myelin repair rather than immune m...
PX1 Research introduces a new line of sublingual peptide strips manufactured in the U.S., offering needle-free alternatives for Retatrutide, Tirzepati...
PX1 Research's new domestic manufacturing protocol applies cGMP quality control and seven-stage HPLC purity verification, ensuring 99%+ purity with ba...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola, potentially offering a more accessibl...
University of Virginia scientists find focused ultrasound may make brain tumors more susceptible to cancer drugs, offering a targeted approach that co...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
Quantum BioPharma's FDA approval to begin Phase 2 trials for its novel MS drug Lucid-MS could herald a shift from immune-modulating therapies to neuro...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, driven by TONMYA's strong sales, while the company progresses its clinical pipeline an...
Tonix Pharmaceuticals announced Q2 2026 revenue of $13.5 million, up from $2 million a year ago, fueled by TONMYA sales, and provided updates on its p...
Tonix Pharmaceuticals reported strong Q2 2026 results with TONMYA driving revenue growth and promising pipeline advances, positioning the company for ...
A comprehensive review in the World Journal of Pediatric Surgery offers a unified framework for diagnosing and treating neuroblastoma, emphasizing ris...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through key clinical and regulatory milestones, potentially offerin...
Quantum BioPharma is progressing its two-pronged approach to neurological health, targeting multiple sclerosis with Lucid-MS and alcohol-related effec...
Quantum BioPharma is progressing two distinct approaches—an investigational MS therapy and a dietary supplement—to address neurological and alcohol-re...
VERAXA Biotech's advanced antibody engineering platform positions it to capitalize on significant pharmaceutical investment in ADCs and T-cell engager...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer highlights the dangers of undercooked pork and the urgent need for imp...
Lantern Pharma announces its Q2 2026 earnings webcast, providing updates on its AI-driven oncology pipeline and the commercial launch of its withZeta....
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its IP portfolio, strengthenin...
A novel liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatme...
GeoVax announced completion of manufacturing, regulatory, clinical, and preclinical milestones for its mpox/smallpox vaccine GEO-MVA, supporting initi...
Nagoya University researchers discovered that the ancient protein C3, when produced by tumor cells, may boost the effectiveness of immunotherapy by ac...
NeuroThera Labs has initiated a Phase IIb clinical trial at Yale Child Study Center for SCI-110, a novel cannabinoid-based treatment for Tourette Synd...
A new study finds that physical activity, even at low levels, is associated with reduced risks of stroke and death for adults with atrial fibrillation...
The United States has exceeded its 2025 measles case count, reaching 2,371 cases, the highest in three decades, as outbreaks spread in multiple states...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital has reached halfway enrollment, with preliminary PET imaging showing en...
Biotech Labz Supply Inc. has broadened its online catalog of high-purity research peptides, now offering 11 compounds with batch-specific certificate ...
Oncotelic Therapeutics will showcase its latest clinical progress, including Phase 1b trial advancement and AI-driven platforms, at the OTCQB Virtual ...
Tonix Pharmaceuticals announced FDA feedback supporting its adaptive Phase 2 study of TNX-4800, a long-acting antibody for Lyme disease prevention, po...
Helus Pharma has named Michael Halstead as its new CEO, bringing extensive biopharmaceutical experience as the company advances its lead depression ca...
Recent independent findings suggest that licensed Ebola vaccines may induce cross-reactive immune responses, supporting broader filovirus vaccine deve...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital has reached halfway enrollment, with early PET imaging signals potentia...
Center for Dental Implants has expanded its specialized implant services to Aventura, offering both surgical placement and restorative care under one ...
VERAXA Biotech has promoted antibody therapeutics specialist Dr. Christoph Erkel to Chief Scientific Officer as the company prepares its proprietary B...
A new preclinical study finds that an experimental therapy containing vitamin B12 could stop the progression of glioblastoma multiforme, the deadliest...
VolitionRx announced increasing clinical support for its Nu.Q NETs assay as a biomarker for sepsis, with studies showing its ability to distinguish se...
Instinct Bio announced a strategic collaboration with INVITRX to manufacture and sell GENREVER cosmetic products in the U.S. and supply exosomes for r...
VERAXA Biotech announced it has filed new patent applications in the first half of 2026, expanding its intellectual property portfolio to over 50 gran...
VERAXA Biotech strengthens its scientific leadership by appointing Dr. Christoph Erkel as Chief Scientific Officer to advance its proprietary BiTAC(R)...
A new study estimates that 28% of U.S. adults with high blood pressure may qualify for medication under updated guidelines, highlighting a treatment g...
Greenland Mines has obtained a Canadian patent for Klotho-based gene therapies, expanding its IP portfolio and advancing candidates for Alzheimer's, P...
Quantum BioPharma's executive discussed the company's strategy for advancing Lucid-MS for multiple sclerosis and the commercial opportunity for unbuzz...
Regentis Biomaterials is progressing its hydrogel-based cartilage repair implant GelrinC through key clinical and regulatory stages, with recent acqui...
Greenland Mines Ltd. announced a Canadian patent for Klotho-based gene therapies targeting cognition, memory, and neurodegenerative diseases, expandin...
A new study aims to understand why some people with cancer risk factors never develop the disease, focusing on the role of autoantibodies in immune re...
NanoViricides has submitted an application to begin a Phase II trial of its NV-387 Oral Gummies for Bundibugyo ebolavirus in the DRC, where no approve...
Lantern Pharma announced EMA clearance for a Phase 1b/2 trial of LP-184 in advanced bladder cancer, using biomarker-guided patient selection.
Physicians at Mayo Clinic Florida report that NeuroOne's OneRF Ablation System, used in 25 epilepsy patients, led to meaningful reductions in seizure ...
GeoVax Labs reports second quarter 2026 financial results and provides business update, highlighting progress toward initiating a pivotal immunobridgi...
